drugset / Trial / NCT02295436

Pharmacokinetics and Tolerability of Minodronic Acid and Food and Age Effects on the Pharmacokinetics

NCT02295436

RandomizedParallel-groupOpen-labelBasic science

Summary

The primary objective of the the study was to evaluate the pharmacokinetic properties of minodronic acid tablets following single and multiple oral administration in healthy Chinese subjects. Additionally, the effects of age and food on minodronic acid pharmacokinetics was also explored.

Timeline

Start
2014-08
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Minodronic acid Small molecule 1 mg Oral
Subject Minodronic acid Small molecule 2 mg Oral
Subject Minodronic acid Small molecule 4 mg Oral

Indications